Initial Study Results Published in American Heart Association’s Stroke Journal Reveal That the Bioness Inc. L300 Produces Significant Walking Improvements and is Preferred by Stroke Survivors With Foot Drop

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness, Inc. today announced that 30-week results from the company’s study of the Bioness L300® Foot Drop System in persons with stroke have been published in the premier journal of the American Heart Association; Stroke. The results demonstrate that persons with drop foot following stroke had significant performance improvements using the Bioness L300 matching that of the standard of care, the ankle foot orthosis (AFO). Subjects who used the Bioness L300 specifically reported significantly greater satisfaction and willingness to continue use of the L300 after 30 weeks.

Help employers find you! Check out all the jobs and post your resume.